Free U.S. Shipping on Orders $100+•$10 Flat-Rate Shipping Under $100
BACK TO LIBRARY
CELLULAR & REGENERATIVE RESEARCH

MOTS-c

Also known as: Mitochondrial ORF of the 12S rRNA type-c

Mitochondrial-Derived Peptide

EVIDENCE: EARLYPRIMARILY PRECLINICAL; HUMAN RESEARCH IS OBSERVATIONAL AND EARLYFOR RESEARCH PURPOSES ONLY.
QUICK FACTS

COMPOUND CLASS

Mitochondrial-derived peptide

PRIMARY PATHWAY

AMPK activation and metabolic stress signaling

PRIMARY AREAS OF RESEARCH

Exercise physiology, insulin sensitivity, mitochondrial signaling

RESEARCH STATUS

Primarily preclinical; human research is observational and early

EVIDENCE LEVEL

Early

OTHER NAMES

Mitochondrial ORF of the 12S rRNA type-c

What Is MOTS-c?

MOTS-c is a short peptide with an unusual origin. Most proteins in your body are built from instructions in the DNA inside a cell's nucleus. MOTS-c is instead encoded by the small, separate set of DNA housed inside mitochondria — the structures that generate cellular energy.

This makes it one of a small group of molecules known as mitochondrial-derived peptides. Their discovery changed how scientists think about mitochondria: not just as passive power plants, but as compartments that send signals to the rest of the cell.

What it is
A small peptide encoded not by nuclear DNA but by DNA inside the mitochondria.
Category
Cellular and metabolic research peptide.
Main system involved
AMPK signaling — the cell's energy-sensing system — and muscle glucose uptake.
Research interest
Metabolic regulation, exercise biology, insulin sensitivity, and mitochondrial communication.
Research status
Discovered in 2015; mostly animal and cell research with limited human data.

Why Are Researchers Interested?

PRECLINICAL RESEARCH

Mitochondria as messengers

It provides direct evidence that mitochondria communicate with the cell nucleus — a significant conceptual shift in cell biology.

PRECLINICAL RESEARCH

Energy sensing via AMPK

Research consistently links MOTS-c to AMPK, the enzyme that acts as the cell's low-fuel alarm.

LIMITED RESEARCH

Exercise biology

Levels have been observed to change with physical activity in studies, making it interesting for exercise physiology research.

LIMITED RESEARCH

Metabolic models

Animal studies have examined insulin sensitivity and glucose handling. These findings are preclinical and not yet confirmed in large human trials.

How It Works

Every cell has a fuel gauge. When energy runs low, an enzyme called AMPK switches on and tells the cell to conserve and generate more fuel: burn stored fat, take in more glucose, build more mitochondria.

MOTS-c appears to work largely by influencing this alarm system. In laboratory studies it also travels to the nucleus and affects which genes are read, particularly genes involved in stress responses and metabolism. In plain terms, it looks like a message sent from the mitochondria saying: adjust the cell's metabolic settings.

Current Areas of Research

LABORATORY RESEARCH

Energy sensing

How MOTS-c interacts with AMPK and what changes downstream.

ANIMAL RESEARCH

Muscle glucose uptake

Whether skeletal muscle takes up glucose more readily in animal models.

HUMAN CLINICAL RESEARCH

Exercise response

How levels shift with physical activity and training.

THEORETICAL MECHANISM

Mitochondria-to-nucleus signaling

How a signal from the mitochondria alters gene activity in the nucleus.

ANIMAL RESEARCH

Aging and metabolism

Observed changes in levels with age, which remain correlational.

What Does the Evidence Actually Say?

EARLY

Early — most findings come from cell and rodent studies, with human data largely limited to observational measurements of natural levels rather than controlled administration trials.

Side Effects & Safety Research

NEUTRAL SUMMARY OF PUBLISHED SAFETY RESEARCH

Possible or theoretical

  • Because it acts on broad metabolic signaling, systemic metabolic effects are theoretically plausible.

Where evidence is insufficient

  • No controlled human safety data of meaningful size has been published.

What We Don't Know Yet

LIMITS OF THE CURRENT EVIDENCE
  • Human clinical evidence is very limited; most findings come from mice and cell cultures.
  • No definitive receptor has been identified, so the entry point of its signal is unclear.
  • Whether age-related changes in levels are a cause or a consequence is unknown.
  • The field is young — MOTS-c was described in 2015, so long-term data does not exist.

Frequently Asked Questions

Research References

  • Lee C et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 2015.
  • Reynolds JC et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications, 2021.
  • Kim SJ, Xiao J, Wan J, Cohen P, Yen K. Mitochondrially derived peptides as novel regulators of metabolism. Journal of Physiology, 2017.

Key Takeaway

KEY TAKEAWAY

MOTS-c is a peptide encoded by mitochondrial DNA, notable as evidence that mitochondria actively signal to the rest of the cell. Research links it to AMPK, the cell's energy-sensing system, and to glucose handling in muscle, mostly in animal and laboratory models. It is an early-stage but conceptually important area of metabolic research.

Related Research

This information is provided for educational purposes only and summarizes current areas of scientific research. It is not medical advice, a treatment recommendation, or an instruction for personal use. Research findings may be preliminary, limited, or subject to change as new evidence becomes available.